176 related articles for article (PubMed ID: 38825437)
1. Recombinant immune complexes as vaccines against infectious diseases.
Kim MY; Mason HS; Ma JKC; Reljic R
Trends Biotechnol; 2024 Jun; ():. PubMed ID: 38825437
[TBL] [Abstract][Full Text] [Related]
2. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
[TBL] [Abstract][Full Text] [Related]
3. Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.
Galili U
Med Res Arch; 2021 Jul; 9(7):. PubMed ID: 34853815
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor-based adjuvants: enhancing the immune response to vaccines against infectious diseases of chicken.
Gupta SK; Deb R; Dey S; Chellappa MM
Expert Rev Vaccines; 2014 Jul; 13(7):909-25. PubMed ID: 24855906
[TBL] [Abstract][Full Text] [Related]
5. Recombinant immune complexes as versatile and potent vaccines.
Mason HS
Hum Vaccin Immunother; 2016 Apr; 12(4):988-9. PubMed ID: 26751099
[TBL] [Abstract][Full Text] [Related]
6. Immune complex-based vaccine for pig protection against parvovirus.
Roić B; Cajavec S; Ergotić N; Lipej Z; Madić J; Lojkić M; Pokrić B
J Vet Med B Infect Dis Vet Public Health; 2006 Feb; 53(1):17-23. PubMed ID: 16460351
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Adjuvant Type on the Immunogenicity of RBD/N Cocktail Antigens as a Vaccine Candidate against SARS-CoV-2 Virus.
Brzuska G; Zimna M; Baranska K; Szewczyk B; Strakova P; Ruzek D; Krol E
Microbiol Spectr; 2023 Jun; 11(3):e0256422. PubMed ID: 37199661
[TBL] [Abstract][Full Text] [Related]
8. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.
Zuckermann FA; Martin S; Husmann RJ; Brandt J
Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035
[TBL] [Abstract][Full Text] [Related]
9. Advancements in protein nanoparticle vaccine platforms to combat infectious disease.
Butkovich N; Li E; Ramirez A; Burkhardt AM; Wang SW
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1681. PubMed ID: 33164326
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in adjuvants for vaccines against infectious diseases.
O'Hagan DT; MacKichan ML; Singh M
Biomol Eng; 2001 Oct; 18(3):69-85. PubMed ID: 11566599
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of live vaccines by co-delivery of immune modulating proteins.
Manohar MM; Campbell BE; Walduck AK; Moore RJ
Vaccine; 2022 Sep; 40(40):5769-5780. PubMed ID: 36064671
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
13. Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases.
Gao X; Wang X; Li S; Saif Ur Rahman M; Xu S; Liu Y
ACS Nano; 2023 Dec; 17(24):24514-24538. PubMed ID: 38055649
[TBL] [Abstract][Full Text] [Related]
14. Engineering DNA vaccines against infectious diseases.
Lee J; Arun Kumar S; Jhan YY; Bishop CJ
Acta Biomater; 2018 Oct; 80():31-47. PubMed ID: 30172933
[TBL] [Abstract][Full Text] [Related]
15. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
Koprowski H
Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
[TBL] [Abstract][Full Text] [Related]
16. Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives.
Wagner A; Weinberger B
Front Immunol; 2020; 11():717. PubMed ID: 32391017
[TBL] [Abstract][Full Text] [Related]
17. Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.
Moyle PM
Biotechnol Adv; 2017; 35(3):375-389. PubMed ID: 28288861
[TBL] [Abstract][Full Text] [Related]
18. Current view on novel vaccine technologies to combat human infectious diseases.
Matić Z; Šantak M
Appl Microbiol Biotechnol; 2022 Jan; 106(1):25-56. PubMed ID: 34889981
[TBL] [Abstract][Full Text] [Related]
19. Adjuvanted leptospiral vaccines: Challenges and future development of new leptospirosis vaccines.
Teixeira AF; Fernandes LGV; Cavenague MF; Takahashi MB; Santos JC; Passalia FJ; Daroz BB; Kochi LT; Vieira ML; Nascimento ALTO
Vaccine; 2019 Jul; 37(30):3961-3973. PubMed ID: 31186193
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
